Wessel N, Gerner T, Grøgaard H K
Kirurgisk avdeling, Lillehammer fylkessykehus.
Tidsskr Nor Laegeforen. 1995 Mar 20;115(8):935-7.
We conducted a survey among the surgical and gynaecological departments of all Norwegian hospitals, about today's practice concerning oral contraceptives and surgery. Most of the surgical and gynaecological departments recommend discontinuance of the pill two and four weeks prior to surgery, and reintroduction upon mobilisation postoperatively. In surgical emergencies amongst women who use the pill, 4/5 surgical and 2/3 gynaecological departments would prefer to give thrombosis prophylaxis. Low molecular weight heparin was recommended most. Surgical departments especially recommend stopping the use of the progestogene only contraceptive pill, and post menopausal oestrogen substitution, before elective surgery. Both gynaecological and surgical departments give inadequate information about the use of alternative birth control during the period when the pill is not taken. The survey did not show any difference between university and central/county hospitals.
我们对挪威所有医院的外科和妇科进行了一项调查，内容是关于当今口服避孕药与手术相关的做法。大多数外科和妇科科室建议在手术前两到四周停用避孕药，并在术后恢复活动时重新开始服用。在服用避孕药的女性发生外科急症时，五分之四的外科科室和三分之二的妇科科室更倾向于进行血栓预防。最常被推荐的是低分子肝素。外科科室特别建议在择期手术前停用仅含孕激素的避孕药以及绝经后雌激素替代疗法。在停用避孕药期间，妇科和外科科室关于使用替代避孕方法的信息都提供得不足。调查未显示大学医院与中心/县医院之间存在差异。
